\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ coronal\\ head\\ ultrasound\ \(0\)\
\-\ right\\ intraparenchymal\\ cerebellar\\ hyperechoic\\ region\ \(1\)\
\-\ no\\ midline\\ shift\ \(5\)\
\-\ no\\ intraventricular\\ hemorrhage\ \(1\)\
\-\ no\\ hydrocephalus\ \(5\)\
\-\ surrounding\\ periventricular\\ deep\\ white\\ matter\\ is\\ unremarkable\ \(1\)\
\-\ right\\ intraparenchymal\\ cerebellar\\ hemorrhage\ \(0\)\
\-\ 1\\.\\ intraparenchymal\\ hemorrhage\\ of\\ the\\ right\\ cerebellum\ \(0\)\
\-\ 2\\.\\ tumor\ \(0\)\
\-\ 3\\.\\ operator\\ error\ \(0\)\
\-\ 24\\+5\\ week\\ old\\ female\\ \\(day\\ four\\ of\\ life\\)\\ who\\ is\\ undergoing\\ repeat\\ head\\ ultrasound\\ screening\\ after\\ negative\\ screening\\ on\\ day\\ one\\ of\\ life\\.\ \(1\)\
\-\ intracranial\\ hemorrhage\\ \\(ich\\)\\ is\\ not\\ an\\ uncommon\\ phenomenon\\ in\\ the\\ premature\\ infant\\.\\ \\ with\\ an\\ incidence\\ of\\ 15\\%\\ in\\ neonates\\ less\\ than\\ 1500\\ grams\\ and\\ less\\ than\\ 32\\ weeks\\,\\ it\\ is\\ the\\ most\\ common\\ intracranial\\ abnormality\\ in\\ this\\ subset\\ of\\ patients\\.\\ \\ the\\ incidence\\ doubles\\ \\(30\\%\\)\\ when\\ the\\ infant\\ is\\ less\\ than\\ 28\\ weeks\\ and\\ less\\ than\\ 1000\\ grams\\.\\ \\ the\\ two\\ factors\\ leading\\ to\\ ich\\ in\\ these\\ premature\\ infants\\ are\\ 1\\.\\ instability\\ of\\ the\\ cardiovascular\\ system\\ and\\ 2\\.\\ the\\ absence\\ of\\ an\\ autoregulatory\\ mechanism\\.\\ \\ the\\ first\\ factor\\ leads\\ to\\ sudden\\ fluctuations\\ in\\ systemic\\ blood\\ pressure\\,\\ and\\ without\\ an\\ autoregulatory\\ system\\ these\\ fluctuations\\ are\\ transmitted\\ directly\\ to\\ the\\ vasculature\\ within\\ the\\ brain\\.\\ \\ \ \(0\)\
\-\ ich\\ tends\\ to\\ occur\\ within\\ the\\ first\\ 3\\ days\\ of\\ life\\.\\ \\ within\\ 72\\ to\\ 96\\ hours\\,\\ 80\\%\\ to\\ 90\\%\\ of\\ ich\\ has\\ occurred\\,\\ and\\ it\\ is\\ rare\\ for\\ ich\\ to\\ occur\\ after\\ the\\ first\\ week\\.\\ \\ the\\ classification\\ of\\ papile\\ and\\ colleagues\\ is\\ used\\ to\\ categorize\\ the\\ severity\\ of\\ ich\\ into\\ four\\ grades\\:\ \(0\)\
\-\ \\ grade\\ 1\\ hemorrhage\\ is\\ described\\ as\\ subependymal\\ hemorrhage\\ at\\ the\\ germinal\\ matrix\\.\\ \\ \ \(0\)\
\-\ \\ grade\\ 2\\ occurs\\ when\\ the\\ germinal\\ matrix\\ ruptures\\ through\\ the\\ ependymal\\ wall\\ and\\ enters\\ the\\ lateral\\ ventricle\\.\\ \\ \ \(0\)\
\-\ \\ grade\\ 3\\ intraventricular\\ hemorrhage\\ causes\\ dilatation\\ of\\ one\\ or\\ both\\ lateral\\ ventricular\\ spaces\\,\\ and\\ in\\ its\\ severe\\ form\\ the\\ ventricular\\ cavity\\ may\\ be\\ completely\\ filled\\ with\\ blood\\.\\ \\ \\ \\ \ \(0\)\
\-\ \\ grade\\ 4\\ hemorrhage\\ is\\ described\\ as\\ intraparenchymal\\ hemorrhage\\ with\\ a\\ highly\\ echogenic\\ focus\\ with\\ irregular\\ margins\\ in\\ the\\ parenchyma\\ typically\\ adjacent\\ to\\ the\\ lateral\\ ventricles\\.\\ \\ \ \(0\)\
\-\ the\\ above\\ mentioned\\ case\\ would\\ be\\ classified\\ as\\ a\\ grade\\ 4\\ hemorrhage\\.\\ \\ the\\ hyperechoic\\ focus\\ in\\ the\\ right\\ cerebellum\\ is\\ typical\\ of\\ an\\ intraparenchymal\\ hemorrhage\\ \\(iph\\)\\.\\ \\ the\\ location\\ of\\ the\\ hemorrhage\\ is\\ atypical\\ given\\ that\\ the\\ most\\ common\\ sites\\ of\\ iph\\ are\\ in\\ the\\ frontal\\ and\\ parietal\\ lobes\\.\\ \\ iph\\ is\\ usually\\ associated\\ with\\ intraventricular\\ hemorrhage\\ and\\ ventricular\\ dilation\\;\\ these\\ aspects\\ that\\ are\\ not\\ found\\ in\\ this\\ case\\.\\ \\ an\\ intracerebellar\\ hemorrhage\\ is\\ thought\\ to\\ be\\ caused\\ by\\ one\\ or\\ more\\ of\\ the\\ following\\ three\\ processes\\:\\ primary\\ hemorrhage\\,\\ venous\\ infarct\\,\\ and\\/or\\ extension\\ of\\ a\\ subarachnoid\\/intraventricular\\ hemorrhage\\ into\\ the\\ cerebellum\\.\\ \\ \ \(0\)\
\-\ the\\ prognosis\\ for\\ a\\ grade\\ 4\\ hemorrhage\\ is\\ related\\ to\\ the\\ severity\\ of\\ parenchymal\\ injury\\.\\ \\ major\\ motor\\ deficits\\ will\\ be\\ present\\ in\\ 90\\%\\ of\\ premature\\ infants\\ with\\ iph\\,\\ and\\ greater\\ than\\ 70\\%\\ will\\ have\\ diminished\\ cognitive\\ function\\.\\ \\ more\\ specific\\ to\\ intracerebellar\\ hemorrhage\\ is\\ a\\ high\\ mortality\\ rate\\ in\\ premature\\ infants\\,\\ and\\ term\\ infants\\ with\\ these\\ lesions\\ suffer\\ with\\ significant\\ neurologic\\ deficits\\.\\ \\ given\\ the\\ severe\\ consequences\\ of\\ ich\\,\\ ultrasound\\ screening\\ protocols\\ have\\ been\\ established\\ for\\ premature\\ infants\\.\\ \\ in\\ the\\ asymptomatic\\ premature\\ infant\\,\\ a\\ screening\\ head\\ ultrasound\\ should\\ be\\ performed\\ between\\ the\\ 7th\\ and\\ 14th\\ days\\ of\\ life\\.\\ \\ if\\ no\\ ich\\ is\\ detected\\,\\ then\\ a\\ repeat\\ head\\ ultrasound\\ should\\ be\\ performed\\ at\\ term\\ \\(36\\-40\\ weeks\\)\\.\\ \\ in\\ the\\ symptomatic\\ premature\\ infant\\,\\ the\\ timeframe\\ for\\ ultrasound\\ screening\\ must\\ be\\ individualized\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ich\\:\\ 0\\.3915975197051403\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.38603507370766627\ \(0\)\
\-\ the\\:\\ 0\\.24288056854147932\ \(0\)\
\-\ premature\\:\\ 0\\.22114589535857188\ \(0\)\
\-\ iph\\:\\ 0\\.19579875985257014\ \(0\)\
\-\ intraparenchymal\\:\\ 0\\.1863640389243434\ \(0\)\
\-\ infants\\:\\ 0\\.16690256862722028\ \(0\)\
\-\ is\\:\\ 0\\.1403559744954488\ \(0\)\
\-\ grade\\:\\ 0\\.13820383777460965\ \(0\)\
\-\ intraventricular\\:\\ 0\\.13352205490177624\ \(0\)\
\-\ of\\:\\ 0\\.1316399471501148\ \(0\)\
\-\ screening\\:\\ 0\\.1301053863295887\ \(0\)\
\-\ ultrasound\\:\\ 0\\.11854850622149049\ \(0\)\
\-\ infant\\:\\ 0\\.11312868747268573\ \(0\)\
\-\ in\\:\\ 0\\.11156016786313715\ \(0\)\
\-\ life\\:\\ 0\\.10511720705770755\ \(0\)\
\-\ autoregulatory\\:\\ 0\\.1024530720593713\ \(0\)\
\-\ fluctuations\\:\\ 0\\.1024530720593713\ \(0\)\
\-\ intracerebellar\\:\\ 0\\.1024530720593713\ \(0\)\
\-\ to\\:\\ 0\\.09609598526600377\ \(0\)\
\-\ and\\:\\ 0\\.09266700276654544\ \(0\)\
\-\ be\\:\\ 0\\.09095941355270545\ \(0\)\
\-\ than\\:\\ 0\\.0907908498939997\ \(0\)\
\-\ cerebellum\\:\\ 0\\.08829008562223523\ \(0\)\
\-\ less\\:\\ 0\\.08716825906384461\ \(0\)\
\-\ grams\\:\\ 0\\.0823302036885866\ \(0\)\
\-\ ventricular\\:\\ 0\\.08083449096757281\ \(0\)\
\-\ germinal\\:\\ 0\\.08059897028772876\ \(0\)\
\-\ head\\:\\ 0\\.07641894157016262\ \(0\)\
\-\ an\\:\\ 0\\.0734941418527339\ \(0\)\
\-\ these\\:\\ 0\\.07235441873760219\ \(0\)\
\-\ first\\:\\ 0\\.0648497083241917\ \(0\)\
\-\ matrix\\:\\ 0\\.06444370698872733\ \(0\)\
\-\ severity\\:\\ 0\\.06318454153102054\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.05897643933203889\ \(0\)\
\-\ weeks\\:\\ 0\\.05759266177375882\ \(0\)\
\-\ repeat\\:\\ 0\\.05619304424501822\ \(0\)\
\-\ incidence\\:\\ 0\\.05514756556213169\ \(0\)\
\-\ deficits\\:\\ 0\\.05506468115143771\ \(0\)\
\-\ one\\:\\ 0\\.055019894850285855\ \(0\)\
\-\ focus\\:\\ 0\\.05426783734055271\ \(0\)\
\-\ cerebellar\\:\\ 0\\.052427247801337756\ \(0\)\
\-\ described\\:\\ 0\\.05197923679487275\ \(0\)\
\-\ four\\:\\ 0\\.051916669576368694\ \(0\)\
\-\ intracranial\\:\\ 0\\.05154841407115143\ \(0\)\
\-\ doubles\\:\\ 0\\.05122653602968565\ \(0\)\
\-\ papile\\:\\ 0\\.05122653602968565\ \(0\)\
\-\ 90\\:\\ 0\\.051191851213189636\ \(0\)\
\-\ term\\:\\ 0\\.05023904385091954\ \(0\)\
\-\ with\\:\\ 0\\.05017851504273102\ \(0\)\
\-\ colleagues\\:\\ 0\\.048949689963142536\ \(0\)\
\-\ categorize\\:\\ 0\\.048949689963142536\ \(0\)\
\-\ timeframe\\:\\ 0\\.048949689963142536\ \(0\)\
\-\ system\\:\\ 0\\.04887453075102884\ \(0\)\
\-\ are\\:\\ 0\\.04861912332899915\ \(0\)\
\-\ lateral\\:\\ 0\\.04769070180837596\ \(0\)\
\-\ occur\\:\\ 0\\.04711613703058676\ \(0\)\
\-\ 14th\\:\\ 0\\.046081203158969075\ \(0\)\
\-\ ruptures\\:\\ 0\\.04505739590371791\ \(0\)\
\-\ consequences\\:\\ 0\\.04505739590371791\ \(0\)\
\-\ within\\:\\ 0\\.04425919531033453\ \(0\)\
\-\ error\\:\\ 0\\.044191779203289004\ \(0\)\
\-\ subset\\:\\ 0\\.044191779203289004\ \(0\)\
\-\ grades\\:\\ 0\\.044191779203289004\ \(0\)\
\-\ individualized\\:\\ 0\\.044191779203289004\ \(0\)\
\-\ given\\:\\ 0\\.044069860873583076\ \(0\)\
\-\ operator\\:\\ 0\\.04344194791083642\ \(0\)\
\-\ protocols\\:\\ 0\\.04344194791083642\ \(0\)\
\-\ week\\:\\ 0\\.04309006960184812\ \(0\)\
\-\ right\\:\\ 0\\.04248006066442407\ \(0\)\
\-\ enters\\:\\ 0\\.04218890909954446\ \(0\)\
\-\ should\\:\\ 0\\.04180207800510682\ \(0\)\
\-\ no\\:\\ 0\\.041666088656919495\ \(0\)\
\-\ 1500\\:\\ 0\\.041653704950902634\ \(0\)\
\-\ suffer\\:\\ 0\\.041653704950902634\ \(0\)\
\-\ will\\:\\ 0\\.041233622033276816\ \(0\)\
\-\ neonates\\:\\ 0\\.0411651018442933\ \(0\)\
\-\ day\\:\\ 0\\.0408079833876915\ \(0\)\
\-\ ependymal\\:\\ 0\\.040715630556930796\ \(0\)\
\-\ days\\:\\ 0\\.04055559553765188\ \(0\)\
\-\ severe\\:\\ 0\\.04055559553765188\ \(0\)\
\-\ transmitted\\:\\ 0\\.04029948514386438\ \(0\)\
\-\ for\\:\\ 0\\.03883491263804385\ \(0\)\
\-\ when\\:\\ 0\\.03869866110285424\ \(0\)\
\-\ as\\:\\ 0\\.03860547109533104\ \(0\)\
\-\ 1000\\:\\ 0\\.03829661504011984\ \(0\)\
\-\ 7th\\:\\ 0\\.03802263907732126\ \(0\)\
\-\ performed\\:\\ 0\\.03790076359898406\ \(0\)\
\-\ blood\\:\\ 0\\.03720621238395523\ \(0\)\
\-\ tends\\:\\ 0\\.037043576228827875\ \(0\)\
\-\ cognitive\\:\\ 0\\.037043576228827875\ \(0\)\
\-\ phenomenon\\:\\ 0\\.03682333649750617\ \(0\)\
\-\ classified\\:\\ 0\\.03682333649750617\ \(0\)\
\-\ common\\:\\ 0\\.03633190584598836\ \(0\)\
\-\ more\\:\\ 0\\.03517825912812325\ \(0\)\
\-\ 96\\:\\ 0\\.03484210570122313\ \(0\)\
\-\ established\\:\\ 0\\.03454649043096305\ \(0\)\
\-\ subependymal\\:\\ 0\\.03413034501789664\ \(0\)\
\-\ into\\:\\ 0\\.03405558190697316\ \(0\)\
\-\ mentioned\\:\\ 0\\.033869116832053396\ \(0\)\
\-\ or\\:\\ 0\\.03343034482130969\ \(0\)\
\-\ most\\:\\ 0\\.03334110240560612\ \(0\)\
\-\ aspects\\:\\ 0\\.03315128216940325\ \(0\)\
\-\ periventricular\\:\\ 0\\.03293104243808156\ \(0\)\
\-\ classification\\:\\ 0\\.03293104243808156\ \(0\)\
\-\ it\\:\\ 0\\.032793718825277395\ \(0\)\
\-\ cardiovascular\\:\\ 0\\.03231784546155291\ \(0\)\
\-\ leads\\:\\ 0\\.03231784546155291\ \(0\)\
\-\ case\\:\\ 0\\.03218530491421784\ \(0\)\
\-\ have\\:\\ 0\\.03200372856393347\ \(0\)\
\-\ directly\\:\\ 0\\.03185349895135351\ \(0\)\
\-\ diminished\\:\\ 0\\.03176506573256257\ \(0\)\
\-\ vasculature\\:\\ 0\\.0315078271691516\ \(0\)\
\-\ processes\\:\\ 0\\.0315078271691516\ \(0\)\
\-\ mortality\\:\\ 0\\.0315078271691516\ \(0\)\
\-\ sites\\:\\ 0\\.03126185821372318\ \(0\)\
\-\ after\\:\\ 0\\.03107873602293489\ \(0\)\
\-\ occurred\\:\\ 0\\.03094981164179851\ \(0\)\
\-\ 72\\:\\ 0\\.03087443610286013\ \(0\)\
\-\ detected\\:\\ 0\\.03072665406508136\ \(0\)\
\-\ instability\\:\\ 0\\.030171595823851507\ \(0\)\
\-\ mechanism\\:\\ 0\\.030171595823851507\ \(0\)\
\-\ factor\\:\\ 0\\.03004099939500979\ \(0\)\
\-\ echogenic\\:\\ 0\\.029372434258043107\ \(0\)\
\-\ spaces\\:\\ 0\\.029147788568600345\ \(0\)\
\-\ undergoing\\:\\ 0\\.02909300380881546\ \(0\)\
\-\ uncommon\\:\\ 0\\.028985012147180054\ \(0\)\
\-\ parenchymal\\:\\ 0\\.028775066448690222\ \(0\)\
\-\ highly\\:\\ 0\\.028672965575255387\ \(0\)\
\-\ completely\\:\\ 0\\.028622602965590528\ \(0\)\
\-\ leading\\:\\ 0\\.028474169829969156\ \(0\)\
\-\ systemic\\:\\ 0\\.028425551402128293\ \(0\)\
\-\ dilation\\:\\ 0\\.02818857981269499\ \(0\)\
\-\ prognosis\\:\\ 0\\.02818857981269499\ \(0\)\
\-\ shift\\:\\ 0\\.028142362322681858\ \(0\)\
\-\ ventricles\\:\\ 0\\.028142362322681858\ \(0\)\
\-\ form\\:\\ 0\\.02800594929868667\ \(0\)\
\-\ major\\:\\ 0\\.02800594929868667\ \(0\)\
\-\ that\\:\\ 0\\.027801587680303354\ \(0\)\
\-\ sudden\\:\\ 0\\.02769997670608565\ \(0\)\
\-\ thought\\:\\ 0\\.02765759617784614\ \(0\)\
\-\ 32\\:\\ 0\\.027450362574717998\ \(0\)\
\-\ must\\:\\ 0\\.027450362574717998\ \(0\)\
\-\ margins\\:\\ 0\\.027329596773211454\ \(0\)\
\-\ factors\\:\\ 0\\.027095588191499983\ \(0\)\
\-\ lobes\\:\\ 0\\.026726021082443836\ \(0\)\
\-\ infarct\\:\\ 0\\.02665493920498943\ \(0\)\
\-\ 28\\:\\ 0\\.02658474587428908\ \(0\)\
\-\ cavity\\:\\ 0\\.02644693789479369\ \(0\)\
\-\ 70\\:\\ 0\\.02644693789479369\ \(0\)\
\-\ atypical\\:\\ 0\\.026279301764426888\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.026148705335585165\ \(0\)\
\-\ dilatation\\:\\ 0\\.026148705335585165\ \(0\)\
\-\ parenchyma\\:\\ 0\\.026021077265917743\ \(0\)\
\-\ function\\:\\ 0\\.02592722449621616\ \(0\)\
\-\ parietal\\:\\ 0\\.025865516256138733\ \(0\)\
\-\ filled\\:\\ 0\\.025774207035575716\ \(0\)\
\-\ caused\\:\\ 0\\.02568435882538577\ \(0\)\
\-\ neurologic\\:\\ 0\\.025595925606594818\ \(0\)\
\-\ absence\\:\\ 0\\.025537734481320455\ \(0\)\
\-\ coronal\\:\\ 0\\.025508863500821845\ \(0\)\
\-\ motor\\:\\ 0\\.025480140198618488\ \(0\)\
\-\ not\\:\\ 0\\.02529113811709155\ \(0\)\
\-\ occurs\\:\\ 0\\.025255494509175726\ \(0\)\
\-\ 80\\:\\ 0\\.024986764126709294\ \(0\)\
\-\ deep\\:\\ 0\\.024934527532933192\ \(0\)\
\-\ typical\\:\\ 0\\.02475543375048437\ \(0\)\
\-\ irregular\\:\\ 0\\.02473030890616591\ \(0\)\
\-\ symptomatic\\:\\ 0\\.024630918818850437\ \(0\)\
\-\ hours\\:\\ 0\\.024413521605097518\ \(0\)\
\-\ matter\\:\\ 0\\.024389877808746813\ \(0\)\
\-\ pressure\\:\\ 0\\.024389877808746813\ \(0\)\
\-\ related\\:\\ 0\\.02434288679530286\ \(0\)\
\-\ specific\\:\\ 0\\.024273129459271563\ \(0\)\
\-\ rate\\:\\ 0\\.024273129459271563\ \(0\)\
\-\ causes\\:\\ 0\\.02420422806308449\ \(0\)\
\-\ at\\:\\ 0\\.02419797024715787\ \(0\)\
\-\ rare\\:\\ 0\\.024181447531487935\ \(0\)\
\-\ midline\\:\\ 0\\.024091238469623074\ \(0\)\
\-\ used\\:\\ 0\\.023980477613713334\ \(0\)\
\-\ its\\:\\ 0\\.023702325084461736\ \(0\)\
\-\ greater\\:\\ 0\\.02359890791957305\ \(0\)\
\-\ ventricle\\:\\ 0\\.023578451090620227\ \(0\)\
\-\ abnormality\\:\\ 0\\.023299615418875135\ \(0\)\
\-\ above\\:\\ 0\\.023108597227930877\ \(0\)\
\-\ venous\\:\\ 0\\.022869608252689196\ \(0\)\
\-\ would\\:\\ 0\\.022675039728549853\ \(0\)\
\-\ extension\\:\\ 0\\.022675039728549853\ \(0\)\
\-\ then\\:\\ 0\\.022675039728549853\ \(0\)\
\-\ typically\\:\\ 0\\.02248698767554085\ \(0\)\
\-\ location\\:\\ 0\\.022305029704001413\ \(0\)\
\-\ this\\:\\ 0\\.022013713689119866\ \(0\)\
\-\ 30\\:\\ 0\\.021851803556360447\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.02180693998879805\ \(0\)\
\-\ 15\\:\\ 0\\.021645440421895833\ \(0\)\
\-\ three\\:\\ 0\\.021502547385087833\ \(0\)\
\-\ unremarkable\\:\\ 0\\.0214743999911294\ \(0\)\
\-\ white\\:\\ 0\\.021133968893710303\ \(0\)\
\-\ injury\\:\\ 0\\.02088837745640615\ \(0\)\
\-\ between\\:\\ 0\\.020813001917467766\ \(0\)\
\-\ adjacent\\:\\ 0\\.020763307846804496\ \(0\)\
\-\ found\\:\\ 0\\.02072632378334096\ \(0\)\
\-\ frontal\\:\\ 0\\.020616811016638408\ \(0\)\
\-\ usually\\:\\ 0\\.020165486158261484\ \(0\)\
\-\ brain\\:\\ 0\\.019968818042055175\ \(0\)\
\-\ negative\\:\\ 0\\.01983094499087774\ \(0\)\
\-\ primary\\:\\ 0\\.01969637613017099\ \(0\)\
\-\ wall\\:\\ 0\\.019485585948133852\ \(0\)\
\-\ following\\:\\ 0\\.019216303168506258\ \(0\)\
\-\ region\\:\\ 0\\.019160242203675033\ \(0\)\
\-\ through\\:\\ 0\\.019068033344648547\ \(0\)\
\-\ two\\:\\ 0\\.019022490569970425\ \(0\)\
\-\ been\\:\\ 0\\.01866234977594445\ \(0\)\
\-\ if\\:\\ 0\\.018611531389863024\ \(0\)\
\-\ significant\\:\\ 0\\.01849471364557765\ \(0\)\
\-\ lesions\\:\\ 0\\.018396482685800037\ \(0\)\
\-\ high\\:\\ 0\\.01820503027858714\ \(0\)\
\-\ who\\:\\ 0\\.018119416247779137\ \(0\)\
\-\ patients\\:\\ 0\\.01801989065223269\ \(0\)\
\-\ both\\:\\ 0\\.01786275413651954\ \(0\)\
\-\ without\\:\\ 0\\.016895805851215025\ \(0\)\
\-\ associated\\:\\ 0\\.016883396137131905\ \(0\)\
\-\ tumor\\:\\ 0\\.01675472355687997\ \(0\)\
\-\ present\\:\\ 0\\.016436786196754736\ \(0\)\
\-\ may\\:\\ 0\\.016119636619256913\ \(0\)\
\-\ female\\:\\ 0\\.015457036492002503\ \(0\)\
\-\ has\\:\\ 0\\.014631396984301465\ \(0\)\
\-\ by\\:\\ 0\\.013602749766507187\ \(0\)\
\-\ on\\:\\ 0\\.009674288350010057\ \(0\)\
\-\ old\\:\\ 0\\.009480256658925202\ \(0\)\
